Studies have shown that CAPE ameliorates myocardial ischemia/reperfusion injury by suppressing oxidative stress and the inflammatory response through the SIRT1/eNOS/NF-κB pathway [27]. This evidence concerns the gene NFKB1 and myocardial ischemia.